The Association of the British Pharmaceutical Industry
Medicines are transforming our lives like never before.
We want the UK to be the best place in the world to research, develop and use the medicines and vaccines of the future.
Latest news and blogs
Blog |
Disclosure UK 2024: new record for transparency, with nine in ten healthcare professionals named in database
Blog |
Why the pharmaceutical industry needs NHS data to develop new medicines
News |
ABPI response to the new Industrial Strategy
News |
Coalition calls for roadmap to improve inclusivity in clinical research
Best practice guidance: Supporting patient organisations to report industry funding
Transparency is essential when pharmaceutical companies work with patient organisations. This updated guidance is aimed at supporting that transparency.
Guidance for conferences and events in the UK: ABPI Code of Practice requirements
This clarifies the ABPI Code requirements for conferences and events, helps all relevant stakeholders operate in a Code-compliant, professional and ethical manner.
2024 ABPI Code of Practice – new resources
The PMCPA has published new webinars and e-learning to aid understanding of the 2024 ABPI Code of Practice.
Lives Lived Well
From patients and their loved ones to those working within the pharmaceutical industry in the UK, we share a common goal: Lives Lived Well.
Events
Online Workshop on SMC: How to prepare and submit to SMC | 08-09 September 2025
Making high quality, evidence-based submissions to SMC can mean the difference between successful or very limited access to NHS Scotland for medicines.
Save the date - ABPI Industry Summit 2025
ABPI Annual Conference 2026
ABPI’s flagship annual conference will be taking place in Central London on 23 April 2026.
ABPI response to NHS 10-Year Health Plan
The NHS 10-Year Health Plan gets it right on genomics and advanced therapies, as well as accelerated clinical trials and supporting participation in research. However, innovative medicines could play a far greater role in revolutionising healthcare. The plan also sends a worrying signal about limiting patient and doctor choices around the best treatment for them.
Key facts and figures for the pharmaceutical industry in the UK
£46.7bn
Turnover [6]
£9bn
investment in UK R&D (more than UKRI’s entire annual budget) [3]
£17.6bn
direct Gross Value Added (GVA) [1]